FDA
The CBD Regulatory Environment in Europe: Part 3
This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here, it is important that we compare apples to apples. […]
FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies
Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different companies for selling copycat food products that contain Delta-8 THC. In a press release published on July 5, the FDA and FTC said they sent out letters to the following companies: Delta Munchies […]
Product Liability in the Cannabis Industry: Insights From 2022 & Looking Forward
In 2022, product liability lawsuits in the cannabis/cannabidiol (CBD) industry continued to focus on levels of THC and the psychoactive ingredient in cannabis, while federal agencies continued issuing warning letters for CBD products (including CBD-infused food and dietary supplements) that made misleading medical claims. Against this backdrop of ongoing litigation and regulatory enforcement, 2022 showed […]
FDA Punts on CBD Rules
On December 20, 2018, Former President Trump signed the Farm Bill into law, which removed hemp-derived cannabidiol (CBD) from the Controlled Substances Act, stripped the DEA’s authority from hemp and gave states the ability to regulate hemp markets of their own, with approval from the USDA. When that Farm Bill became law, it paved the […]
CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid
Whether for greed or science, the DEA has reduced restrictions on researching the CBD cannabinoid. Last week rumor, innuendo, and hope filled the air. As the charitable season of Christmas took hold, there was a glimmer of hope that the DEA (Drug Enforcement Administration) could be on the precipice of a historic decision, downgrading the Schedule I status of […]
Marijuana Shows Promise For MS Treatment
I It might be time for you to start explaining marijuana as “a harmful, addictive, opiate based killer that ruins lives.” The concept has labored well for legal opiate based pain relievers. Citing marijuana’s actual medical qualities has been doing little to pressure the federal government to do something. But new pain relievers, like the terrifying Zohydro, easily obtain the …continue reading through
Marijuana Shows Great Potential in Dealing with MS
It might be time for you to start explaining marijuana as “a harmful, addictive, opiate based killer that ruins lives.” The concept has labored well for legal opiate based pain relievers. Citing marijuana’s actual medical qualities has been doing little to pressure the federal government to do something. But new pain relievers, like the terrifying Zohydro, easily obtain the eco-friendly light in the Food and drug administration despite alerts from leaders within the medical area. Even as patient recommendations and clinical research flows in highlighting the positive impact of medicinal marijuana, we’re stuck waiting around the federal government bodies meet up with the relaxation from the electorate.
A week ago, the American Academy of Neurology launched new recommendations regarding the management of ms. MS could be debilitating and effective remedies have alluded doctors for a long time. With the possible lack of consistent effectiveness around the party from the traditional remedies, many patients happen to be made to seek complementary and alternative medications (CAM). There’s formerly not been much when it comes to research concentrating on the prosperity of CAM remedies, until lately. The American Academy of Neurology is finally searching to alter that. They lately launched their findings with different overview of 291 studies and research which involve CAM remedies for MS patients.
Lead author from the review and clinical director of Or Health insurance and Science University’s Ms Center, Dr. Vijayshree Yadav, stated “This may be the first review, evidence-based recommendation, on treating MS with CAM treatments.” He continued to state “there were 29 different treatments incorporated within the recommendations. 19 studies checked out cannabis.” The types of cannabis intake analyzed, however, were using dental cannabis extract and artificial THC. Scientists discovered that these remedies were good at treating discomfort for approximately twelve months, but didn’t address the tremors frequently connected with MS.
Losing effectiveness continues to be credited with other conditions given synthetic marijuana. Patients who’ve used medications for example Sativex have regularly reported benefits that rapidly dissipate. When we would inject good sense as it were, it appears an all natural type of Sativex, say naturally growing marijuana, would without doubt be safer on our bodies. MS scientists don’t have many details on using actual marijuana because they are mostly avoided by federal law to review real cannabis. This research is among many read about this highlights the advantages of marijuana. It really makes a person question if our chosen authorities are reading through, or if they’re even literate.
 
Colorado Study Shows Need For Regulation and Marijuana Testing
As the election season continues we are pretty much ensured that the political conversation will remain within the narrow scope of only a handful of issues being discussed until January. While healthcare will be part of the next two months, it will only likely find its way in the campaign through the lens of Obamacare vs. Romneycare.
For many patients who only find relief with marijuana, this will be yet another election where their concerns will not be addressed. Ignoring and tolerating medical marijuana to some extent is no longer going to be acceptable. Medication needs to be safe and with a far less rate of addiction and side effects in comparison to opiates and other medication, cannabis already satisfies much of the criteria for useful medicine. However, with it’s legal status constantly in limbo, cannabis has suffered from a lack of regulation and required testing as many elected officials hope that 75% of the country soon changes its mind and stops supporting medical marijuana. That seems highly unlikely and our elected officials have chosen to ignore the safety of Americans in favor of outdated talking points and rhetoric. Simply put, marijuana is here to stay, and providing safe medicine must be a concern.
Shedding more light on the problem is a recent study conducted in Colorado. Dr. John Martyny of the National Jewish Health studied the findings from 30 grow operations in the Larimer and Denver areas. The research indicated that certain grows had mold levels about 100 times higher than what is considered safe. In some growing operations, the mold levels were too high to for their instruments to properly measure. Dr. Martyny said “These are extremely high levels that we would consider dangerous.” Fortunately, none of the growing operations studied were legal, giving at least some hope that Colorado medical marijuana patients are not breathing in high levels of mold.
However, there is evidence that even legal growers are not taking the proper precautions in preventing high levels of mold. The Werc Shop also finds similar problems when conducting laboratory analysis, but unlike Dr. Martyny they DO test cannabis from legal dispensaries. In a recent conversation with marijuana.net, Dr. Jeffrey C. Raber of the Los Angeles area lab said “We have had numerous secret shoppers find instances of mold and bacteria present at unacceptable, sometimes alarmingly high levels.” The Werc Shop is one of the most well regarded testing laboratories and was responsible for much of the screening for the 2012 High Times Los Angeles Cannabis Cup.
Research shows that we may only be hitting the tip of the iceberg in regards to just how much potential medical marijuana holds. However, as with any consumable product, improper testing and screening invites devastating side effects. The high levels of mold found by both Dr. Martyny and Dr. Raber only highlight the need for regulation and testing. The products created by large Pharmaceutical companies have to abide by FDA standards and a lack of regulation would not be accepted even for over the counter medicines. As the national campaigns ignores this problem, it is up to patients and activists to demand for regulation, testing, and safety.
Canadian Government Decides to Invest in Hemp
The criminalization of marijuana has caused some head scratching for decades. Why exactly are naturally growing buds with few side effects (certainly far less than many FDA approve drugs”) and a wealth of medical potential illegal? Lobbyists? Political stubbornness? Lack of Compassion? Well if we cannot these questions about why our government has outlawed marijuana …continue reading